Affordable Access

Genetic modification of liver grafts with an adenoviral vector encoding the Bcl-2 gene improves organ preservation.

Authors
Type
Published Article
Journal
Transplantation Journal
0041-1337
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
67
Issue
6
Pages
775–783
Identifiers
PMID: 10199723
Source
Medline
License
Unknown

Abstract

We have demonstrated a novel approach to reducing the preservation injury to liver grafts with the human Bcl-2 gene. This approach may allow a longer preservation time, potentially reduce the incidence of primary nonfunction, decrease the immunogenicity of the cold injured organ, and increase the safer use of "marginal" liver grafts.

Statistics

Seen <100 times